Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Theravance Biopharma (TBPH) Current Taxes: 2014-2025

Historic Current Taxes for Theravance Biopharma (TBPH) over the last 1 years, with Sep 2025 value amounting to $4.1 million.

  • Theravance Biopharma's Current Taxes was N/A to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year change of. This contributed to the annual value of $5.9 million for FY2024, which is N/A change from last year.
  • Theravance Biopharma's Current Taxes amounted to $4.1 million in Q3 2025, which was down 84.74% from $26.7 million recorded in Q2 2025.
  • Theravance Biopharma's Current Taxes' 5-year high stood at $26.7 million during Q2 2025, with a 5-year trough of $4.1 million in Q3 2025.
  • Its 2-year average for Current Taxes is $10.6 million, with a median of $5.9 million in 2025.